ARYX (ARYX) Stock Price & Analysis

ARYX (ARYX) rose 0.00% to USD 0 as of June 10, 2026 at 02:35 UTC, according to Nexqual real-time market data.

ARYX last closed at USD 0; the session ranged USD 0–0 on volume of 2,000 shares. Market capitalization is $16,730, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 02:35 UTC.

Key Statistics (as of June 10, 2026 at 02:35 UTC)

PriceUSD 0
Change▲ 0.00% (up)
Previous CloseUSD 0
OpenUSD 0
Day RangeUSD 0 – 0
52-Week RangeUSD 0 – 0
Volume2,000 shares
Market Cap$16,730
ExchangePNK

Technical Analysis (ARYX)

Nexqual's technical model rates ARYX "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:35 UTC.

Overall SignalBUY
RSI (14)100 (overbought)
vs SMA50Below (USD 0)
MACD0 (negative)

Analyst Ratings (ARYX)

Wall Street analysts rate ARYX "None", per Nexqual as of June 10, 2026 at 02:35 UTC.

Consensus RatingNone

Earnings (ARYX)

Recent Earnings History

QuarterActual vs Estimate
2010-09-30USD -0.08 vs est -0.09 ▲ beat
2010-06-30USD -0.11 vs est -0.1 ▼ miss
2010-03-31USD -0.22 vs est -0.17 ▼ miss
2009-12-31USD -0.21 vs est -0.23 ▲ beat

Source: Nexqual, June 10, 2026 at 02:35 UTC.

Financials & Fundamentals (ARYX)

Gross Margin+0.00%
Operating Margin+0.00%
Profit Margin+0.00%
Current Ratio0.47
Total Cash$2.95M
Total Debt$11.57M
Free Cash Flow$-10.64M

Source: Nexqual, June 10, 2026 at 02:35 UTC.

Financial Health Score (ARYX)

Nexqual rates ARYX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:35 UTC.

GrowthCritical — Revenue -100% YoY (annual), sharp decline
ProfitabilityWeak — Pre-revenue or very early stage
Balance SheetMixed — $3M cash vs $12M debt
Cash FlowWeak — Operating cash flow -$20M
EfficiencyMixed — No data

Ownership (ARYX)

Insider Ownership+0.00%
Institutional Ownership+0.00%
Shares Outstanding33.46M
Short % of Float+0.39%

Source: Nexqual, June 10, 2026 at 02:35 UTC.

Peers & Related Stocks

SymbolNamePriceChange
PARDPONIARD PHARMACEUTUSD 0▲ 0%
AOLSAEOLUS PHARMACEUTICALS INCUSD 0▲ 0%
AFFYAFFYMAX INCUSD 0▲ 0%
VIAPVIA PHARMACEUTICALS INCUSD 0▲ 0%
MYRXMyrexis, Inc.USD 0▲ 0%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:35 UTC. This page is informational and not investment advice.